Christian D. Klein

5.5k total citations · 1 hit paper
101 papers, 4.5k citations indexed

About

Christian D. Klein is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Organic Chemistry. According to data from OpenAlex, Christian D. Klein has authored 101 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 35 papers in Public Health, Environmental and Occupational Health and 22 papers in Organic Chemistry. Recurrent topics in Christian D. Klein's work include Mosquito-borne diseases and control (33 papers), Malaria Research and Control (24 papers) and Peptidase Inhibition and Analysis (16 papers). Christian D. Klein is often cited by papers focused on Mosquito-borne diseases and control (33 papers), Malaria Research and Control (24 papers) and Peptidase Inhibition and Analysis (16 papers). Christian D. Klein collaborates with scholars based in Germany, United States and Egypt. Christian D. Klein's co-authors include Christoph Nitsche, Mira A. M. Behnam, Christian Steuer, Ralf Bartenschlager, Veaceslav Boldescu, Dominik Graf, Linlin Zhang, Rolf Hilgenfeld, Nikos Vasilakis and Alexander Neugebauer and has published in prestigious journals such as Science, Chemical Reviews and Proceedings of the National Academy of Sciences.

In The Last Decade

Christian D. Klein

96 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor

2016 289 citations Christoph Nitsche, Christian D. Klein et al. profile →

Peers

Countries citing papers authored by Christian D. Klein

Since Specialization

Citations

This map shows the geographic impact of Christian D. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian D. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian D. Klein more than expected).

Fields of papers citing papers by Christian D. Klein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian D. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian D. Klein. The network helps show where Christian D. Klein may publish in the future.

Co-authorship network of co-authors of Christian D. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Christian D. Klein. A scholar is included among the top collaborators of Christian D. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian D. Klein. Christian D. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Late‐Stage Amination of Peptides on the Solid Phase 2025 ·Chemistry - A European Journal ·(unknown), (unknown), (unknown), (unknown), Christian D. Klein, (unknown), Franziska Thomas	0
2	Towards "unmakable" psychedelics: SAR exploration of psilocin analogs obtained by a HATU-mediated amide coupling strategy 2025 ·European Journal of Medicinal Chemistry Reports ·(unknown), (unknown), Harald Hübner, (unknown), Christian D. Klein	0
3	Exploring Nirmatrelvir Derivatives Through P2 Substituent Modifications and Warhead Innovations Targeting the Main Protease of SARS‐CoV‐2 2025 ·Archiv der Pharmazie ·(unknown), (unknown), (unknown), Xianxian Wang, (unknown), Jerônimo Lameira, Christian D. Klein, Carlos A. Montanari	0
4	Antiviral drug discovery with an optimized biochemical dengue protease assay: Improved predictive power for antiviral efficacy 2024 ·Antiviral Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christian D. Klein	1
5	Peptide Boronic Acids by Late‐Stage Hydroboration on the Solid Phase 2024 ·Advanced Science ·(unknown), (unknown), (unknown), Thomas M. Heim, (unknown), (unknown), Christian D. Klein, Franziska Thomas	2
6	Alternate recognition by dengue protease: Proteolytic and binding assays provide functional evidence beyond an induced-fit 2024 ·Biochimie ·Mira A. M. Behnam, Christian D. Klein	2
7	Expanding Per- and Polyfluoroalkyl Substances Coverage in Nontargeted Analysis Using Data-Independent Analysis and IonDecon 2023 ·Journal of the American Society for Mass Spectrometry ·Jeremy P. Koelmel, Michael P. Kummer, Olivier Chevallier, Ralph Hindle, (unknown), (unknown), (unknown), Emily L. Gill, Chris Beecher, Timothy J. Garrett, Richard A. Yost, Timothy G. Townsend, Christian D. Klein, Emma E. Rennie, John A. Bowden, Krystal J. Godri Pollitt	6
8	2,2′-Bithiophene as sensor tag for ligand–protein binding assays based on Förster resonance energy transfer 2023 ·Analytical Biochemistry ·Mira A. M. Behnam, Thomas Basché, Christian D. Klein	1
9	Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay 2021 ·SLAS DISCOVERY ·(unknown), (unknown), Mila M. Leuthold, Mira A. M. Behnam, Christian D. Klein	19
10	The spectrum between substrates and inhibitors: Pinpointing the binding mode of dengue protease ligands with modulated basicity and hydrophobicity 2021 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Christian D. Klein	2
11	Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria 2019 ·European Journal of Medicinal Chemistry ·Eman M.E. Dokla, Nader S. Abutaleb, (unknown), Daoyi Li, (unknown), (unknown), (unknown), Maha Nasr, Christian D. Klein, Khaled A. M. Abouzid, Mohamed N. Seleem	56
12	Identification of fused bicyclic derivatives of pyrrolidine and imidazolidinone as dengue virus-2 NS2B-NS3 protease inhibitors 2016 ·European Journal of Medicinal Chemistry ·(unknown), Xiao‐Xia Shao, Dominik Graf, Chunguang Wang, Christian D. Klein, Jing Wang, Guo‐Chun Zhou	41
13	S1 pocket fingerprints of human and bacterial methionine aminopeptidases determined using fluorogenic libraries of substrates and phosphorus based inhibitors 2011 ·Biochimie ·Marcin Poręba, Anna Gajda, Jan Pícha, Jiřı́ Jiráček, (unknown), Christian D. Klein, Guy S. Salvesen, Marcin Drąg	17
14	Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases 2011 ·Bioorganic & Medicinal Chemistry ·Christoph Nitsche, Christian Steuer, Christian D. Klein	85
15	Structure–activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Christian D. Klein	31
16	Optimization of Assay Conditions for Dengue Virus Protease: Effect of Various Polyols and Nonionic Detergents 2009 ·SLAS DISCOVERY ·Christian Steuer, (unknown), Lars Kattner, Christian D. Klein	46
17	Development and Evaluation of a FACS-Based Medium-Throughput Assay for HCV Entry Inhibitors 2009 ·SLAS DISCOVERY ·(unknown), Bernd Kronenberger, (unknown), Artur Kaul, (unknown), Christian D. Klein, Rolf W. Hartmann	6
18	Aspergillus fumigatus und Angiogenese. Von einer Zufallsentdeckung zum Rationalen Drug‐Design 2007 ·Pharmazie in unserer Zeit ·Christian D. Klein	1
19	Molecular modeling and bioinformatical analysis of the antibacterial target enzyme MurA from a drug design perspective 2006 ·Journal of Computer-Aided Molecular Design ·Christian D. Klein, (unknown)	18
20	Pharmacological Activity and Membrane Interactions of Antiarrhythmics: 4D-QSAR/QSPR Analysis 1998 ·Pharmaceutical Research ·Christian D. Klein, A. J. Hopfinger	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact